<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21192875</article-id>
      <article-id pub-id-type="pmc">3204654</article-id>
      <article-id pub-id-type="publisher-id">10-1443</article-id>
      <article-id pub-id-type="doi">10.3201/eid1701.101443</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Carbapenemases in Enterobacteria, Hong Kong, China, 2009</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Chu</surname>
            <given-names>Yiu-Wai</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tung</surname>
            <given-names>Viola W.N.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cheung</surname>
            <given-names>Terence K.M.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chu</surname>
            <given-names>Man-Yu</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>Naomi</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lai</surname>
            <given-names>Christopher</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsang</surname>
            <given-names>Dominic N.C.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lo</surname>
            <given-names>Janice Y.C.</given-names>
          </name>
        </contrib>
        <aff id="aff1">Author affiliations: Centre for Health Protection, Hong Kong Special Administrative Region, People&#x2019;s Republic of China (Y.-W. Chu, V.W.N. Tung, T.K.M. Cheung, M.-Y. Chu, J.Y.C. Lo);</aff>
        <aff id="aff2">Queen Elizabeth Hospital, Hong Kong (N. Cheng, C. Lai, D.N.C. Tsang)</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Yiu-Wai Chu, Public Health Laboratory Centre, 382 Nam Cheong St, Kowloon, Hong Kong Special Administrative Region, People&#x2019;s Republic of China; email: <email xlink:href="alf@dh.gov.hk">alf@dh.gov.hk</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2011</year>
      </pub-date>
      <volume>17</volume>
      <issue>1</issue>
      <fpage>130</fpage>
      <lpage>132</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>NDM-1</kwd>
        <kwd>IMI-3</kwd>
        <kwd>IMP-4</kwd>
        <kwd>metallo-&#x3B2;-lactamase</kwd>
        <kwd>class A carbapenemase</kwd>
        <kwd>bacteria</kwd>
        <kwd>Hong Kong</kwd>
        <kwd>enterobacteria</kwd>
        <kwd>expedite</kwd>
        <kwd>letter</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> Carbapenems are often the recommended treatment for serious infections caused by extended-spectrum &#x3B2;-lactamase&#x2013;producing enterobacteria. However, enzyme-mediated carbapenem resistance is increasingly reported worldwide. Carbapenemases are represented by 3 molecular classes of &#x3B2;-lactamase: A, B, and D (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>). The best known class A carbapenemase is <italic>Klebsiella</italic> <italic>pneumoniae</italic> carbapenemase (KPC); KPC-producing enterobacteria are responsible for many hospital outbreaks. Class B carbapenemases are metallo-&#x3B2;-lactamases (MBL), which have the widest substrate spectrum. Class D OXA-type carbapenemases are found mainly in nonfermenting bacteria, except for OXA-48, which has been found only in enterobacteria.</p>
    <p>In Hong Kong Special Administrative Region, People&#x2019;s Republic of China, the Public Health Laboratory Centre routinely provides microbiological diagnostic services for government outpatient clinics and confirms the identity of bacterial isolates referred by other clinical laboratories. In 2009, among 18 enterobacteria isolates determined to be not susceptible to carbapenem, only 4 isolates&#x2014;<italic>Citrobacter freundii</italic>, <italic>Enterobacter cloacae</italic>, <italic>Escherichia coli</italic>, and <italic>K. pneumoniae</italic>&#x2014;were confirmed to produce carbapenemase. The <italic>E. coli</italic> isolate was from a government outpatient clinic; the others were from a regional hospital laboratory (Table).</p>
    <p>For all 4 isolates, the modified Hodge test (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>) demonstrated enzyme activity against ertapenem and meropenem. Previously described PCR and sequencing methods (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>) identified the MBL IMP-4 in the <italic>C. freundii</italic> and <italic>K. pneumoniae</italic> isolates; the <italic>C. freundii</italic> isolate also possessed extended-spectrum &#x3B2;-lactamase CTX-M-9. The <italic>E. coli</italic> isolate harbored the recently described MBL called New Delhi metallo-&#x3B2;-lactamase (NDM-1) (GenBank accession no. FN396876) from India (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). The <italic>E. cloacae</italic> isolate possessed a class A carbapenemase IMI-like (Nmc-type) gene, and DNA sequencing confirmed its 97.2% nt and 97.6% aa identity to IMI-1. This IMI allele was subsequently designated IMI-3 (GenBank accession no. GU015024). For all 4 enterobacteria isolates, PCR was negative for OXA-48.</p>
    <p>MIC determination by Etest and VITEK 2 (bioM&#xE9;rieux, Marcy l&#x2019;Etoile, France) showed that all 4 isolates were resistant to ampicillin, amoxicillin/clavulanate, piperacillin/tazobactam, cefoxitin, cefuroxime, cefotaxime, and ceftazidime, according to Clinical and Laboratory Standards Institute breakpoints (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). Because IMI-1 was inhibited by clavulanate and tazobactam, the corresponding resistance in the IMI-3 positive <italic>E. cloacae</italic> isolate might result from other mechanisms, possibly AmpC &#x3B2;-lactamase, although PCR results for common AmpC alleles were negative (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>).</p>
    <p>All 4 isolates showed resistance to all 3 carbapenems according to the Clinical and Laboratory Standards Institute MIC criteria updated in June 2010 (Table), except for the NDM-1 positive <italic>E. coli</italic> isolate, which had an intermediate MIC for meropenem of 2 &#x3BC;g/mL. The IMP-4 positive <italic>C. freundii</italic> and <italic>K. pneumoniae</italic> isolates also seemed to be more multidrug resistant; they were resistant to nalidixic acid, ciprofloxacin, nitrofurantoin, and co-trimoxazole and susceptible to only amikacin and gentamicin. Conversely, the 2 organisms harboring IMI-3 and NDM-1 were susceptible to all these agents except for the NDM-1&#x2013;positive <italic>E. coli</italic>, which was resistant to amikacin and gentamicin.</p>
    <p>IMP-4 in <italic>Acinetobacter</italic> was first described in 2001 in a teaching hospital in Hong Kong (<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>). Since then, IMP-4 has been detected in several enterobacteria from mainland China and Australia. IMP-4 has spread throughout Hong Kong, crossing geographic and genus barriers; other new carbapenemases are also emerging. The association of IMP-4 with integrons and conjugative plasmids has been documented and possibly contributed to its propensity to spread. IMI-1 in <italic>E. cloacae</italic> was originally described in the United States in 1996. In 2005, IMI-2 (99% aa identity to IMI-1) in <italic>Enterobacter asburiae</italic> isolated from rivers in the United States was reported (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>), and in 2006, a blood culture <italic>E. cloacae</italic> was found to possess IMI-2 in Hangzhou, China (<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>).</p>
    <p>We report IMI-3 (aa identity 97.6% to IMI-2) in a urine isolate of <italic>E. cloacae</italic>, possibly a colonizer rather than the causative agent of the urinary tract infection because the urine specimen did not contain any leukocytes. The 2 IMP-4&#x2013;positive enterobacteria isolates were also only transiently present; repeated cultures did not yield any carbapenem-resistant organisms despite the patients not having received any targeted therapy. Nonetheless, the presence of these transferable resistance determinants among patients with prolonged hospitalization is cause for concern. The NDM-1&#x2013;positive <italic>E. coli</italic> isolate came from an outpatient of Indian ethnicity, who had hypertension, diabetes, and a urinary tract infection that responded to ciprofloxacin. This isolate was thought to have originated from the Indian subcontinent, where the patient had spent 3 weeks in March 2009; he had not been hospitalized in India. A similar case of travel-related NDM-1&#x2013;positive <italic>E. coli</italic> isolated from urine has also been recently reported in Australia (8).</p>
    <p>NDM-1 has the potential to be a worldwide public health problem (<xref ref-type="bibr" rid="R9"><italic>9</italic></xref>). Our findings highlight the threat of carbapenemase-mediated resistance. Scrupulous surveillance must be maintained, and clinical microbiology laboratories should have adequate knowledge and capacity to identify these resistance determinants. To control the dissemination of these resistance determinants, coordinated infection control responses are needed at local, national, and international levels (<xref ref-type="bibr" rid="R10"><italic>10</italic></xref>).</p>
    <table-wrap id="Ta" position="float">
      <label>Table</label>
      <caption>
        <title>Antimicrobial susceptibility results and ESBL detected for 4 carbapenemase-harboring enterobacteria isolates, Hong Kong, 2009*</title>
      </caption>
      <table frame="hsides" rules="groups">
        <col width="52" span="1"/>
        <col width="31" span="1"/>
        <col width="45" span="1"/>
        <col width="45" span="1"/>
        <col width="25" span="1"/>
        <col width="25" span="1"/>
        <col width="25" span="1"/>
        <col width="27" span="1"/>
        <col width="27" span="1"/>
        <col width="31" span="1"/>
        <col width="27" span="1"/>
        <col width="27" span="1"/>
        <col width="27" span="1"/>
        <col width="65" span="1"/>
        <thead>
          <tr>
            <th rowspan="2" valign="bottom" align="left" scope="col" colspan="1">Organism</th>
            <th rowspan="2" valign="bottom" align="center" scope="col" colspan="1">Patient age, y/ sex</th>
            <th rowspan="2" valign="bottom" align="center" scope="col" colspan="1">Patient location</th>
            <th rowspan="2" valign="bottom" align="center" scope="col" colspan="1">Specimen</th>
            <th valign="bottom" colspan="9" align="center" scope="colgroup" rowspan="1">MIC, &#x3BC;g/mL (CLSI breakpoint for resistance)&#x2020;<hr/></th>
            <th rowspan="2" valign="bottom" align="center" scope="col" colspan="1">ESBL/&#x2028;carbapenemase detected</th>
          </tr>
          <tr>
            <th valign="bottom" colspan="1" align="center" scope="colgroup" rowspan="1">IMP&#x2028;(<underline>&gt;</underline>4)</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">MEM (<underline>&gt;</underline>4)</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">ERT&#x2028;(<underline>&gt;</underline>1)</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">NA&#x2028;(<underline>&gt;</underline>32)</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">CIP&#x2028;(<underline>&gt;</underline>4)</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">NIT (<underline>&gt;</underline>128)</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">AK&#x2028;(<underline>&gt;</underline>64)</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">GN&#x2028;(<underline>&gt;</underline>16)</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">SXT (<underline>&gt;</underline>80)</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
              <italic>Citrobacter freundii</italic>
            </td>
            <td valign="top" align="center" rowspan="1" colspan="1">69/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Hospital</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Sputum</td>
            <td valign="top" align="center" rowspan="1" colspan="1">8</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>16</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>8</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>32</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>4</td>
            <td valign="top" align="center" rowspan="1" colspan="1">128</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>2</td>
            <td valign="top" align="center" rowspan="1" colspan="1">8</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>320</td>
            <td valign="top" align="center" rowspan="1" colspan="1">IMP-4, CTX-M-9</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
              <italic>Klebsiella pneumoniae</italic>
            </td>
            <td valign="top" align="center" rowspan="1" colspan="1">60/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Hospital</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Bedsore</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>16</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>16</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>8</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>32</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>4</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>512</td>
            <td valign="top" align="center" rowspan="1" colspan="1">16</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>1</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>320</td>
            <td valign="top" align="center" rowspan="1" colspan="1">IMP-4</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
              <italic>Enterobacter cloacae</italic>
            </td>
            <td valign="top" align="center" rowspan="1" colspan="1">68/F</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Hospital</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Urine</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>16</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>16</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>8</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>0.25</td>
            <td valign="top" align="center" rowspan="1" colspan="1">64</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>2</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>1</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>20</td>
            <td valign="top" align="center" rowspan="1" colspan="1">IMI-3</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
              <italic>Escherichia coli</italic>
            </td>
            <td valign="top" align="center" rowspan="1" colspan="1">64/M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Outpatient clinic</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Urine</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>2</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>0.25</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>16</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>256</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&gt;</underline>16</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><underline>&lt;</underline>20</td>
            <td valign="top" align="center" rowspan="1" colspan="1">NDM-1</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <p>*ESBL, extended-spectrum &#x3B2;-lactamase; IMP, imipenem; MEM, meropenem; ERT, ertapenem; NA, nalidixic acid; CIP, ciprofloxacin; NIT, nitrofurantoin; AK, amikacin; GN, gentamicin; SXT, co-trimoxazole; NDM-1, New Delhi metallo-&#x3B2;-lactamase.&#x2028;&#x2020;CLSI, Clinical and Laboratory Standards Institute, updated June 2010.</p>
      </table-wrap-foot>
    </table-wrap>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Chu Y-W, Tung VWN, Cheung TKM, Chu M-Y, Cheng N, Lai C, et al. Carbapenemases in enterobacteria, Hong Kong, China, 2009 [letter]. Emerg Infect Dis [serial on the Internet]. 2011 Jan [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid1701.101443">http://dx.doi.org/10.3201/eid1701.101443</ext-link></p>
      </fn>
    </fn-group>
    <ack>
      <p>This work was supported by the Government of Hong Kong, China.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Queenan</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Bush</surname> <given-names>K</given-names></string-name> <article-title>Carbapenemases: the versatile &#x3B2;-lactamases.</article-title> <source>Clin Microbiol Rev</source>. <year>2007</year>;<volume>20</volume>:<fpage>440</fpage>&#x2013;<lpage>58</lpage>  <pub-id pub-id-type="doi">10.1128/CMR.00001-07</pub-id><pub-id pub-id-type="pmid">17630334</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="book"><collab>Clinical and Laboratory Standards Institute</collab> Performance standards for antimicrobial susceptibility testing: 20th informational supplement (update 2010 Jun). Document M100&#x2013;S20-U. Wayne (PA): The Institute; <year>2010</year></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Yong</surname> <given-names>D</given-names></string-name>, <string-name><surname>Toleman</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Giske</surname> <given-names>CG</given-names></string-name>, <string-name><surname>Cho</surname> <given-names>HS</given-names></string-name>, <string-name><surname>Sundman</surname> <given-names>K</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>K</given-names></string-name>, <etal/> <article-title>Characterization of a new metallo-&#x3B2;-lactamase gene, <italic>bla</italic><sub>NDM-1</sub>, and a novel erythromycin esterase gene carried on a unique genetic structure in <italic>Klebsiella pneumoniae</italic> sequence type 14 from India.</article-title> <source>Antimicrob Agents Chemother</source>. <year>2009</year>;<volume>53</volume>:<fpage>5046</fpage>&#x2013;<lpage>54</lpage>  <pub-id pub-id-type="doi">10.1128/AAC.00774-09</pub-id><pub-id pub-id-type="pmid">19770275</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Jacoby</surname> <given-names>GA</given-names></string-name> <article-title>AmpC &#x3B2;-lactamases.</article-title> <source>Clin Microbiol Rev</source>. <year>2009</year>;<volume>22</volume>:<fpage>161</fpage>&#x2013;<lpage>182</lpage>  <pub-id pub-id-type="doi">10.1128/CMR.00036-08</pub-id><pub-id pub-id-type="pmid">19136439</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Chu</surname> <given-names>YW</given-names></string-name>, <string-name><surname>Afzal-Shah</surname> <given-names>M</given-names></string-name>, <string-name><surname>Houang</surname> <given-names>ET</given-names></string-name>, <string-name><surname>Palepou</surname> <given-names>MI</given-names></string-name>, <string-name><surname>Lyon DJ</surname></string-name>, Woodford N, et al. <article-title>IMP-4, a novel metallo-beta-lactamase from nosocomial <italic>Acinetobacter</italic> spp. collected in Hong Kong between 1994 and 1998.</article-title> <source>Antimicrob Agents Chemother</source>. <year>2001</year>;<volume>45</volume>:<fpage>710</fpage>&#x2013;<lpage>4</lpage>  <pub-id pub-id-type="doi">10.1128/AAC.45.3.710-714.2001</pub-id><pub-id pub-id-type="pmid">11181348</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Aubron</surname> <given-names>C</given-names></string-name>, <string-name><surname>Poirel</surname> <given-names>L</given-names></string-name>, <string-name><surname>Ash</surname> <given-names>RJ</given-names></string-name>, <string-name><surname>Nordmann</surname> <given-names>P</given-names></string-name> <article-title>Carbapenemase-producing <italic>Enterobacteriaceae</italic>, US rivers.</article-title> <source>Emerg Infect Dis</source>. <year>2005</year>;<volume>11</volume>:<fpage>260</fpage>&#x2013;<lpage>4</lpage><pub-id pub-id-type="pmid">15752444</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Yu</surname> <given-names>YS</given-names></string-name>, <string-name><surname>Du</surname> <given-names>XX</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>ZH</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>YG</given-names></string-name>, <string-name><surname>Li</surname> <given-names>LJ</given-names></string-name> <article-title>First Isolation of <italic>bla</italic><sub>IMI-2</sub> in an <italic>Enterobacter cloacae</italic> clinical isolate from China.</article-title> <source>Antimicrob Agents Chemother</source>. <year>2006</year>;<volume>50</volume>:<fpage>1610</fpage>&#x2013;<lpage>1</lpage>  <pub-id pub-id-type="doi">10.1128/AAC.50.4.1610-1611.2006</pub-id><pub-id pub-id-type="pmid">16569898</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Poirel</surname> <given-names>L</given-names></string-name>, <string-name><surname>Lagrutta</surname> <given-names>E</given-names></string-name>, <string-name><surname>Taylor</surname> <given-names>P</given-names></string-name>, <string-name><surname>Pham</surname> <given-names>J</given-names></string-name>, <string-name><surname>Nordmann</surname> <given-names>P</given-names></string-name> <article-title>Emergence of metallo-beta-lactamase NDM-1-producing multidrug resistant <italic>Escherichia coli</italic> in Australia.</article-title> <source>Antimicrob Agents Chemother</source>. <year>2010</year>;<volume>54</volume>:<fpage>4914</fpage>&#x2013;<lpage>6</lpage>  <pub-id pub-id-type="doi">10.1128/AAC.00878-10</pub-id><pub-id pub-id-type="pmid">20823289</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Kumarasamy</surname> <given-names>KK</given-names></string-name>, <string-name><surname>Toleman</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Walsh</surname> <given-names>TR</given-names></string-name>, <string-name><surname>Bagaria</surname> <given-names>J</given-names></string-name>, <string-name><surname>Butt</surname> <given-names>F</given-names></string-name>, <string-name><surname>Balakrishnan</surname> <given-names>R</given-names></string-name>, <etal/> <article-title>Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.</article-title> <source>Lancet Infect Dis</source>. <year>2010</year>;<volume>10</volume>:<fpage>597</fpage>&#x2013;<lpage>602</lpage>  <pub-id pub-id-type="doi">10.1016/S1473-3099(10)70143-2</pub-id><pub-id pub-id-type="pmid">20705517</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Bilavsky</surname> <given-names>E</given-names></string-name>, <string-name><surname>Schwaber</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Carmeli</surname> <given-names>Y</given-names></string-name> <article-title>How to stem the tide of carbapenemase-producing <italic>Enterobacteriaceae</italic>?: proactive versus reactive strategies.</article-title> <source>Curr Opin Infect Dis</source>. <year>2010</year>;<volume>23</volume>:<fpage>327</fpage>&#x2013;<lpage>31</lpage>  <pub-id pub-id-type="doi">10.1097/QCO.0b013e32833b3571</pub-id><pub-id pub-id-type="pmid">20581673</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
